Financials

  • Market Capitalization 204.52 M
  • Employee 146
  • Founded 2002
  • CEO John Nicols
  • Website www.codexis.com
  • Headquarter Delaware, United States
  • FIGI BBG000RN0GZ5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.26
Price to sales ratio
2.02

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3607
CLLS
Cellectis S.A. - American Depositary Shares
2.89 USD-3.34%-10.80%-6.77%+25.65%207.36 M USD
3613
SLGL
Sol-Gel Technologies Ltd. - Ordinary Shares
73.91 USD-0.05%+0.03%+1.25%+833.21%205.92 M USD
3629
NKTX
Nkarta, Inc. - Common Stock
2.79 USD-6.06%-15.20%-6.69%+47.62%199.61 M USD
3630
IMUX
Immunic, Inc. - Common Stock
14.64 USD-0.88%-1.61%+4.87%+1622.35%199.42 M USD

Frequently asked questions about Codexis, Inc. - Common Stock

What is the Codexis, Inc. - Common Stock stock price today?

The current price of Codexis, Inc. - Common Stock (CDXS) is 2.25. Over the past 24 hours, the stock has changed by -7.41%. Follow the CDXS chart for real-time price dynamics.

What is the stock ticker of Codexis, Inc. - Common Stock?

Codexis, Inc. - Common Stock trades under the ticker CDXS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Codexis, Inc. - Common Stock stock going up?

CDXS has changed by -14.45% over the last week, -9.27% over the last month, and -27.18% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Codexis, Inc. - Common Stock net income for the last quarter?

Codexis, Inc. - Common Stock reported net income of -8.7 M for the last quarter. The previous quarter showed 9.6 M, which means net income changed by -190.66%.

How many employees does Codexis, Inc. - Common Stock have?

As of the latest available data, Codexis, Inc. - Common Stock has 146 employees. Workforce size can provide additional context about the company's scale and operations.

What is Codexis, Inc. - Common Stock EBITDA?

Codexis, Inc. - Common Stock EBITDA is -6.76 M, and its EBITDA margin is -44.31%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Codexis, Inc. - Common Stock stock?

You can buy Codexis, Inc. - Common Stock (CDXS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Codexis, Inc. - Common Stock stock?

Investing in Codexis, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CDXS chart and related analysis on metatrader.com as part of your research.

Codexis, Inc. - Common Stock

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

News